SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005286-24-000128
Filing Date
2024-08-29
Accepted
2024-08-29 16:03:18
Documents
17
Period of Report
2024-08-28
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20240828.htm   iXBRL 8-K 48241
2 EX-10.1 rlakeemploymentagreementex.htm EX-10.1 54893
3 EX-99.1 pressrelease-chieffinanc.htm EX-99.1 9468
7 pressrelease-chieffinanc001.jpg GRAPHIC 363159
8 pressrelease-chieffinanc002.jpg GRAPHIC 79094
  Complete submission text file 0001005286-24-000128.txt   868216

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240828.xsd EX-101.SCH 1983
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240828_lab.xml EX-101.LAB 21885
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240828_pre.xml EX-101.PRE 12591
19 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240828_htm.xml XML 2690
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0526
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 241263514
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)